Previous close | 0.1258 |
Open | 0.1258 |
Bid | 0.0000 x 20000 |
Ask | 0.0000 x 19100 |
Day's range | 0.1258 - 0.1258 |
52-week range | 0.1024 - 1.2420 |
Volume | |
Avg. volume | 13 |
Market cap | 4.58M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
VANCOUVER, Wash., March 14, 2024--BowFlex Inc. ("BowFlex" or "the Company") announced that its Common Stock has been assigned the symbol "BFXXQ" with respect to quotations on the over-the-counter (OTC) market, following its delisting from the New York Stock Exchange.
VANCOUVER, Wash., March 05, 2024--BowFlex Inc. (NYSE: BFX) ("BowFlex" or "the Company") today announced that it has entered into a purchase agreement with Johnson Health Tech Retail, Inc. (the "Stalking Horse Bidder") to serve as the stalking horse bidder to acquire substantially all of the assets of the Company for $37,500,000 in cash at the closing of the transaction, less closing adjustment amounts for accounts receivable, inventory and certain transfer taxes. In order to facilitate the sale
VANCOUVER, Wash., December 01, 2023--BowFlex Inc. (NYSE: BFX) received written notice on November 27, 2023, from the New York Stock Exchange (NYSE) that the Company is not in compliance with the NYSE continued listing standards, which require it to maintain an average global market capitalization of at least $50.0 million over a consecutive 30-day trading period and, at the same time, a total stockholders’ equity equal to or greater than $50.0 million.